ALAMEDA, Calif., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that its Board of Directors has retained two independent financial advisors to support its strategic objectives. RBC Capital Markets and Pacific Growth Equities LLC have been engaged to oversee the review of merger and acquisition opportunities and assist in monetizing the company's AV411 assets, as outlined in the recent Open Letter to Shareholders.
